Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001548 · ClinicalTrials.gov registry record
Genetics of Obsessive-Compulsive Disorder
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 1,067
- Enrollment target
NCT00001548 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 1,067 participants.
The verdict
NCT00001548 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 1,067 participants
- Enrollment target
Study Summary
The purpose of this study is to identify genes that affect susceptibility to obsessive-compulsive disorder (OCD). By identifying genes that increase or decrease the risk of OCD, researchers can better understand how the condition develops and ultimately improve treatment for people with OCD. OCD is a severe, familial condition that affects approximately 2% of the population. The way OCD is inherited is not clearly understood, but researchers believe it is complex and involves multiple genes. This study will detect and localize genes that increase or decrease susceptibility to OCD. The data collected from this study will be combined with data from other research studies to determine gene linkage and association.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,067 participants |
| Start Date | 1996-08-22 |
| Est. Completion | 2015-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001548
The ClinicalTrials.gov registry entry for NCT00001548 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,067 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001548 about?
NCT00001548 is a clinical study titled "Genetics of Obsessive-Compulsive Disorder". The purpose of this study is to identify genes that affect susceptibility to obsessive-compulsive disorder (OCD). By identifying genes that increase or decrease the risk of OCD, researchers can better understand how the condition develops and ultimately improve treatment for people with OCD. OCD is...
What is the current status of trial NCT00001548?
This trial is currently completed. The enrollment target is 1,067 participants. The study started on 1996-08-22. Estimated completion is 2015-09-29.
Who is sponsoring clinical trial NCT00001548?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.